GPT and Cirrhosis: In a cohort study of 3665 CHB patients without cirrhosis, the incidence of HCC was significantly reduced in both groups of patients with ALT < 2 × ULN or ≥ 2 × ULN after antiviral therapy, and there was no significant difference in the degree of reduction in HCC incidence between the two groups [27].